Evaluation of treatment efficacy of metastatic breast cancer

Evaluation of treatment efficacy of metastatic breast cancer - PET Recurrence

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030410

Enrollment

Registered

2017-12-15

Start date

2014-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

FDG-PET examination after start of treatment between 2 to 6 weeks.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Metastatic breast cancer patients

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Progression free survival according to metabolic response of FDG-PET.	—

Countries

Japan

Contacts

Public ContactYasuo Miyoshi

Hyogo College of medicine Division of Breast and Endocrine, Department of Surgery

ymiyoshi@hyo-med.ac.jp0798456374

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026